Protara Therapeutics Inc. (NASDAQ: TARA)
$2.40
+0.0200 ( +0.84% ) 227.6K
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
Market Data
Open
$2.40
Previous close
$2.38
Volume
227.6K
Market cap
$49.42M
Day range
$2.28 - $2.61
52 week range
$1.04 - $5.24
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Jun 10, 2024 |
4 | Insider transactions | 1 | Jun 10, 2024 |
4 | Insider transactions | 1 | Jun 10, 2024 |
4 | Insider transactions | 1 | May 31, 2024 |
4 | Insider transactions | 1 | May 23, 2024 |
4 | Insider transactions | 1 | May 17, 2024 |
4 | Insider transactions | 1 | May 10, 2024 |
8-k | 8K-related | 15 | May 02, 2024 |
10-q | Quarterly Reports | 74 | May 02, 2024 |
ars | Annual reports | 1 | Apr 26, 2024 |